A Fear of Lawsuits Really Does Seem to Result in Extra Medical Tests
Doctors are known for complaining about how the malpractice system adds costs. But it has been hard to prove, until now. (Source: NYT Health)
Source: NYT Health - July 23, 2018 Category: Consumer Health News Authors: MARGOT SANGER-KATZ Tags: Malpractice Health Insurance and Managed Care Doctors Research Tests (Medical) Medicine and Health Source Type: news

AHRA: 4 ways to avoid lawsuits in radiology
Getting sued certainly isn't on the list of a radiology professional's goals....Read more on AuntMinnie.comRelated Reading: Suit alleges that Duke, UNC signed noncompete pact Tackling medicolegal concerns in PACS: Part 2 Breast imaging at highest risk for medicolegal claims No second chance: Lawsuits set to rise across the board Ga. tech in mammo fraud hit with monetary damages (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 23, 2018 Category: Radiology Source Type: news

Little Rock Attorneys Ask Judge Holmes to Rethink Sanctions
Two Little Rock lawyers have asked the chief federal judge for the Western District of Arkansas to reconsider sanctions he imposed on them after a string of cases in which he was critical of their law firm’s work. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - July 23, 2018 Category: American Health Source Type: news

South Africa:NGOs Chose Patients Like 'Slave Owners Choosing New 'Possessions'
[Bhekisisa] A former director says court cases and provincial power prohibited national officials from stopping the Gauteng health department's deadly plans. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 23, 2018 Category: African Health Source Type: news

AARP Foundation - Legal Advocacy: Employment Discrimination. - AARP Foundation
Make a Tax-Deductible Gift Help AARP Foundation increase economic opportunity and social connectedness that can prevent and reduce senior poverty. (Source: AARP.org News)
Source: AARP.org News - July 22, 2018 Category: American Health Source Type: news

UK faces calls to liberalize Northern Ireland abortion laws
The British government is facing rising calls to liberalize abortion laws in Northern Ireland (Source: ABC News: Health)
Source: ABC News: Health - July 22, 2018 Category: Consumer Health News Tags: Health Source Type: news

Emergency Doctors Sue Anthem Over ER Insurance Policy
Doctors filed a lawsuit against Anthem s Blue Cross Blue Shield of Georgia seeking to end a policy that denies coverage for some emergency room care. (Source: AARP.org News)
Source: AARP.org News - July 21, 2018 Category: American Health Source Type: news

Mental health of young adults with lesbian parents is same as their peers
Comparing relationships, educational/job performance, and behavioral, emotional and mental health problems, researchers from the Williams Institute at UCLA School of Law found that 25-year-olds raised by lesbian parents do as well on multiple measures of psychological health as other adults.The findings are contained in the latest edition of the ongoing U.S. National Longitudinal Lesbian Family Study, which in its 32nd year is the longest-running prospective study on sexual minority parent families. This is the first NLLFS report based on data collected when the offspring were legal adults.“When I began this study in...
Source: UCLA Newsroom: Health Sciences - July 21, 2018 Category: Universities & Medical Training Source Type: news

Bayer Throws in the Towel on Essure Birth Control Implant
Bayer said Friday it will stop selling its Essure birth control system in the United States at the end of the year, citing a decline in U.S. sales of the device and the conclusion that the Essure business is no longer sustainable. Although the controversial product is the subject of nearly 30,000 adverse event reports to FDA and thousands of patient lawsuits, Bayer insisted in a statement Friday that its decision to discontinue sales of the product is for business reasons only, "not for any safety or efficacy concerns about Essure." The company added that the benefit-risk profile of Essure has not changed an...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news

United Therapeutics $216m deal for SteadyMed clears HRS Act waiting period
United Therapeutics (NSDQ:UTHR) said today that it stepped closer to completing its $216 million acquisition of SteadyMed (NSDQ:STDY) after terminating the the HSR Act waiting period. The merger combines two companies that were in court as recently as last November, fighting over patents covering treprostinil, the active ingredient in both companies’ lead products. Read the whole story on our sister site, Drug Delivery Business News The post United Therapeutics $216m deal for SteadyMed clears HRS Act waiting period appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Drug-Device Combinations Mergers & Acquisitions Pharmaceuticals Vascular SteadyMed Therapeutics United Therapeutics Source Type: news

Bayer to Stop Selling Controversial Birth Control Device That Sparked Thousands of Lawsuits
Bayer announced Friday that it will no longer sell a controversial, permanent form of birth control that thousands of women say led to serious complications. Essure, a non-surgical sterilization device that is inserted into the fallopian tubes and prevents pregnancy by producing scar tissue that blocks sperm from fertilizing eggs, will no longer be available in the U.S. after December 31, 2018, Bayer announced in a statement. “This decision is based on a decline in U.S. sales of Essure in recent years and the conclusion that the Essure business is no longer sustainable,” the statement reads. While Bayer mainta...
Source: TIME: Health - July 20, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime medicine onetime Source Type: news

Bayer Pulls Controversial Birth Control Device That Sparked Thousands of Lawsuits
Bayer announced Friday that it will no longer sell a controversial, permanent form of birth control that thousands of women say led to serious complications. Essure, a non-surgical sterilization device that is inserted into the fallopian tubes and prevents pregnancy by producing scar tissue that blocks sperm from fertilizing eggs, will no longer be available in the U.S. after December 31, 2018, Bayer announced in a statement. “This decision is based on a decline in U.S. sales of Essure in recent years and the conclusion that the Essure business is no longer sustainable,” the statement reads. While Bayer mainta...
Source: TIME: Health - July 20, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime medicine onetime Source Type: news

FDA announces halt to U.S. Essure sales by Bayer
The FDA said today that Bayer will no longer sell or distribute its Essure permanent birth control device in the US, effective December 31. FDA Commissioner Scott Gottlieb said the action follows a “series of earlier actions that the FDA took to address the reports of serious adverse events associated with its use,” according to an FDA release. “For women who have received an Essure implant, the postmarket safety of Essure will continue to be a top priority for the FDA. We expect Bayer to meet its postmarket obligations concerning this device,” Gottlieb said in a prepared statement. In April, the fe...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Women's Health Bayer Source Type: news

Bayer Stops U.S. Sale of Essure Birth Control Implant
FRIDAY, July 20, 2018 -- Amid lawsuits and plummeting sales for its Essure birth control device, Bayer announced Friday that it would cease U.S. sales of the product by the end of 2018. The announcement comes after years of claims by thousands of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2018 Category: Pharmaceuticals Source Type: news

AngioDynamics to pay $13m to settle False Claims charges
AngioDynamics (NSDQ:ANGO) agreed to pay a total of nearly $13 million to settle charges that it broke the False Claims Act for a chemotherapy delivery device and a peripheral vein treatment. Latham, N.Y.-based AngioDynamics distributed the LC Bead embolization microspheres made by BTG (LON:BTG) subsidiary Biocompatibles. Although cleared for embolizations, the companies allegedly marketed LC Bead from May 2006 through December 2011 as a drug-delivery vehicle for chemotherapy agents, according to federal prosecutors in New York and Texas. The company admitted no liability in agreeing to the settlements, they ...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Drug-Device Combinations Legal News AngioDynamics Source Type: news

B. Braun to Pick Up NxStage ’s Bloodlines Business
Braun Medical is set to acquire NxStage Medical’s bloodlines business. The potential acquisition is subject to Federal Trade Commission approval and is contingent upon the closing of the $2 billion merger between NxStage and Waltham, MA-based Fresenius Medical Holdings. The bloodlines business is operated under the Medisystems name. “We are pleased to add the Streamlinebloodline to our dialysis product portfolio,” Sam Amory, Vice President of B. Braun Medical, said in a release. “Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamlin...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

‘ An Almond Doesn ’t Lactate ’ : FDA To Crack Down On Soy, Almond ‘ Milk ’
WASHINGTON, DC (CBS Local) – The Food and Drug Administration has a message for soy and almond milk drinkers: you’re not drinking milk and your bottle labels may change very soon. FDA Commissioner Scott Gottlieb addressed the agency’s enforcement of “standards of identity” during a Politico media event in Washington. Gottlieb says the FDA will begin cracking down on companies marketing non-dairy products as “milk.” “If you look at our standard of identity, there is a reference somewhere in the standard of identity to a lactating animal,” the FDA chie...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 20, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News almond milk FDA Local TV soy milk talkers Source Type: news

U.S. court rejects Allergan bid to shield patents through tribe deal
A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe. (Source: Reuters: Health)
Source: Reuters: Health - July 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tendyne investors sue Abbott over $50m milestone
Investors in Tendyne Holdings yesterday sued Abbott (NYSE:ABT) over a $50 million milestone payment, alleging that the healthcare giant dragged its heels on obtaining a regulatory approval that would have triggered a $50 million milestone payment. Abbott in September 2015 paid $225 million up front for the stake it didn’t already own in Roseville, Minn.-based Tendyne, which was developing a transcatheter replacement mitral valve. The deal also included a $50 million milestone provision contingent on the device winning CE Mark approval in the European Union before Dec. 31, 2017, and that ...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Mergers & Acquisitions Replacement Heart Valves Abbott Tendyne Holdings Source Type: news

Medtronic agrees to $43m deal to settle shareholder Infuse lawsuit
Medtronic (NYSE:MDT) shareholders are seeking approval for a $43 million settlement deal to clear up claims related to its Infuse bone graft product, according to court documents. Shareholders in the case allege that Fridley, Minn.-based Medtronic engaged “in a scheme and course of conduct to defraud the investing public” in regards to clinical trials of the Infuse bone graft to inflate stock prices. Plaintiffs in the case filed a class action complaint in November 2013, according to court documents, and after a protracted dispute said they believe a settlement is the best move for the class. “Plaint...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Legal News Orthopedics Medtronic Source Type: news

UNISON lawyer wins major human rights award
UNISON legal officer Shantha David has been named Human Rights Lawyer of the Year by the civil rights campaigner Liberty. Ms David was honoured for her leading role in UNISON’s landmark legal victory last year, when the union successfully defeated the government over its introduction of employment tribunal fees. This is the latest of a series of awards won by the in-house legal team, for taking and winning the case. Ms David led the litigation for four and a half years, through the High Court and Court of Appeal, before the Supreme Court unanimously found in the union’s favour. The judges ruled that the fees or...
Source: UNISON Health care news - July 20, 2018 Category: UK Health Authors: Demetrios Matheou Tags: Article News employment rights employment tribunal fees Employment tribunals legal services Source Type: news

Bayer Stops U.S. Sale of Essure Birth Control Implant
FRIDAY, July 20, 2018 -- Amid lawsuits and plummeting sales for its Essure birth control device, drug giant Bayer announced Friday that it would cease U.S. sales of the product by the end of 2018. " This decision is based on a decline in U.S. sales... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 20, 2018 Category: General Medicine Source Type: news

Merck to lower prices on some drugs, but not its blockbusters
The move follows recent announcements by Pfizer and Novartis that they would freeze price increases for the rest of the year, as the industry confronts sustained criticism from President Donald Trump, lawmakers and the public over the rising cost of prescriptions. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2018 Category: Pharmaceuticals Authors: Katie Thomas Source Type: news

Malawi:Malawi's outdated abortion laws sending women to graves : CSO's petition in full
[Nyasa Times] As the world commemorates fourth five Civil Society Organizations met at Linde Motel in Dowa where it was observed that section 149, 150 and 151 is contributing significantly towards the deaths of women in Malawi. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 20, 2018 Category: African Health Source Type: news

Judge: Glyphosate Plaintiffs' Experts Are Admissible In Case Against Monsanto
SAN FRANCISCO - A federal judge in California on July 10 ruled that the experts for plaintiffs who have sued Monsanto Co. in multidistrict litigation related to the herbicide Roundup should be admitted because the plaintiffs have presented evidence from which a reasonable jury could conclude that glyphosate, the active ingredient in Roundup, can cause non-Hodgkin lymphoma (NHL) at "human-relevant doses" (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Carcinogenicity Of Glyphosate Debated At Opening Of Trial Against Monsanto
SAN FRANCISCO - The attorney for a man who claims that Monsanto Co. is responsible for his cancer on July 9 opened a bellwether trial in California state court by contending that the company has known since 1998 that its herbicide Roundup, which contains the active ingredient glyphosate, is connected to non-Hodgkin lymphoma (NHL), yet it failed to warn consumers (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

New York Panel Suspends Attorney's License In Lago Agrio Case Against Chevron
NEW YORK - A New York appellate panel on July 10 suspended the license to practice law for Steven R. Donziger, the attorney who represented a group of Ecuadorian residents who won an $18.5 billion judgment against the company in a court in Ecuador for injuries only to have it reversed (In the Matter of Steven R. Donziger: Attorney Grievance Committee for the First Judicial Department, Petitioner, Steven R. Donziger, Respondent, No. M-5635, N.Y. Sup., App. Div., 1st Dept.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Additional C8 Case Alleging DuPont Is Liable For Kidney Cancer Sent To MDL
WASHINGTON, D.C. - The Judicial Panel on Multidistrict Litigation (JPMDL) on July 10 transferred another case against E.I. du Pont de Nemours and Co. for alleged injuries connected to exposure to perfluorooctanoic acid (known as C8) to the MDL in the U.S. District Court for the Southern District of Ohio (In re: E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, No. 13-2433, S.D. Ohio). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Colorado Residents: 3M Co.'s Attempt To Exclude Expert In Tainted Water Case Fails
DENVER - The plaintiffs in the lead case against 3M Co. and other chemical manufacturers in Colorado federal court on July 11 filed a brief arguing that the defendants' motion to exclude the opinions of their expert in the groundwater contamination case related to aqueous film forming foam (AFFF) should be denied because the expert's opinions are "relevant and reliable" (David Bell, et al. v. 3M Company, et al., No. 16-2351, D. Colo.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Judge: Sherwin-Williams Co. Not Entitled To Dismissal In Lead-Paint Injury Cases
MILWAUKEE - A federal judge in Wisconsin on July 13 denied a motion to dismiss a group of lead-paint injury lawsuits as they pertain to the Sherwin-Williams Co., concluding that the plaintiffs did not need to establish a prerequisite need for applying the risk contribution theory with regard to Sherwin-Williams specifically (Glenn Burton v. American Cyanamid, et al., No. 07-0303, E.D. Wis.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Lead Case Properly Dismissed, Panel Says; Tenant Was Notified Of Hazard
ANNAPOLIS, Md. - A panel of the Maryland Court of Special Appeals on July 12 denied an appeal of a man who contends that the Housing Authority of Baltimore City (HABC) is liable for his lead-based paint injuries, ruling that the man's mother had been notified about the dangers of "blood lead levels and the introduction of lead into the body by eating paint chips containing lead" (John Wright v. Housing Authority of Baltimore City, No. 2163, Sept. Term 2015; 2018 Md. App. LEXIS 695). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Groups: Injunction Proper In Groundwater Case Involving Marina On Raritan River
TRENTON, N.J. - Two environmental groups on July 16 filed a brief in New Jersey federal court contending that their motion for a preliminary injunction should be granted against NL Industries Inc. related to claims that the company and others violated the Clean Water Act (CWA) when they discharged pollutants in levels that exceeded federal permits and contaminated local groundwater. Moreover, the groups insist that the defendants' argument that the motion is not ripe because of plans to build a marina on the river should be rejected (Raritan Baykeeper, et al. v. NL Industries Inc., et al., No. 09-4117, D. N.J.). (Source: L...
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Judge Officially Closes Vinyl Chloride Case Related To Paulsboro Train Derailment
TRENTON, N.J. - The federal judge presiding over the lawsuit brought by New Jersey residents who contended that they were exposed to vinyl chloride as a result of a train derailment officially terminated the case on July 2 nearly one year after a panel of the Third Circuit U.S. Court of Appeals issued a mandate that the case lacked federal jurisdiction (In re: Paulsboro Derailment Cases, No. 13-784, D. N.J.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

3M, DuPont, Others Deny Groundwater Claims, Say Couple Fails To State Case
ALBANY, N.Y. - The four companies that manufactured perfluorooctanoic acid (PFOA), including 3M Co. and E.I. du Pont de Nemours& Co., being sued by a couple who contends that the companies are liable for cancer and other injuries due to groundwater contamination filed separate answers on July 13, denying the allegations and contending that the plaintiffs fail to state a claim upon which relief can be granted (Kenneth Wickenden, et al. v. Saint-Gobain Performance Plastics Corp., et al., No. 17-1056, N.D. N.Y.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Michigan Workers' Comp Exclusivity Bars Asbestos, Mercury Claims, Court Says
TROY, Mich. - Wastewater supervisors with general knowledge about mercury and asbestos hazards who withheld information regarding potential exposures to those toxins from employees do not meet the standard for finding actual knowledge and intent to injure necessary to escape the state's workers' compensation exclusivity provision, a Michigan appeals court held June 26 (Troy Williams, et al. v. East Lansing, et al., Nos. 335467, 335662, Mich. App., 2018 Mich. App. LEXIS 2733). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Government Report: 43 Percent Of School Districts Have Water Tainted With Lead
WASHINGTON, D.C. - The U.S. Government Accountability Office (GAO) released a report on July 17 in which it estimated that 43 percent of school districts in the United States, which serve 35 million students, have drinking water that contains lead. (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 20, 2018 Category: Medical Law Source Type: news

Using Predictive Analytics for Population Health Management and Public Health Emergencies: Ethical, Legal, and Policy Considerations
As the field of public health informatics continues to evolve its capacity for predictive analytics, ethical and legal challenges remain in terms of maintaining privacy and developing sound policies and infrastructure to support data usage, data sharing, and standardized practices. (Source: PHPartners.org)
Source: PHPartners.org - July 19, 2018 Category: International Medicine & Public Health Source Type: news

"Hurt a pretty lady": Lawyer charged with sending threats to herself
Julia Ezell charged with two felonies and one misdemeanor for allegedly sending the threats and then lying to investigators about it (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 19, 2018 Category: Consumer Health News Source Type: news

France Needs'Food Safety Police' to Avoid New Lactalis Crisis - Report France Needs'Food Safety Police' to Avoid New Lactalis Crisis - Report
France should appoint a"food safety police" and increase fines on those who sell contaminated products to avoid a repeat of the salmonella outbreak at a Lactalis milk factory last year that led to dozens of babies falling ill, lawmakers said.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Violent criminal behavior in the context of bipolar disorder: systematic review and meta-analysis - Verdolini N, Pacchiarotti I, K öhler CA, Reinares M, Samalin L, Colom F, Tortorella A, Stubbs B, Carvalho AF, Vieta E, Murru A.
BACKGROUND: Despite the potential importance of understanding violent criminal behavior (VCB) in individuals suffering from bipolar disorder (BD), previous findings are conflicting. The aims of the present study are to clarify the association of VCB and BD... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

The neo-criminalization of stalking in the Portuguese legal system - Nunes Ferreira David M.
Despite the theme stalking was only being given attention in the final decades of the 20th century, the truth is that this phenomenon has always existed. It consists in a series of persistent harassment behaviour of which one person is the victim of anothe... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Responding to the marauding terror attack: the police perspective - Wheatley S, Hollingsworth AC, Greaves I.
UKpolice forces have had to adapt their tactical approach to the emerging terror threat that now faces the UK. This has led to an evolution in the training, education and conduct of authorised firearms officers and an increased capability in the provision ... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Agreement on reporting intimate partner violence among Nepalese couples: a cross-sectional study - Yoshikawa K, Shakya TM, Poudel KC, Jimba M.
When intimate partner violence (IPV) data are collected from only one partner, they are often subject to considerable reporting bias. However, it is not easy to collect such data from couples, and inaccuracies might result in discrepancies, which needs a r... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Fast-growing emergency center co. files Ch. 11, to sell assets
Houston-based Neighbors Legacy Holdings Inc. and 48 other related entities filed for Chapter 11 bankruptcy protection late last week. Additionally, the company has already lined up a buyer for its Houston-area emergency centers, according to court documents. In a statement sent to the Houston Business Journal, Neighbors noted it filed for Chapter 11 to “expedite the sale of its Houston and non-Houston operations.” “The c ompany has sufficient liquidity to continue its normal business operations,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 19, 2018 Category: Health Management Authors: Olivia Pulsinelli Source Type: news

B Braun inks deal to buy NxStage ’ s bloodlines biz
B. Braun said today it inked a deal to acquire the NxStage Medical‘s (NSDQ:NXTM) bloodlines business, which operates under the Medisystems moniker. Bethlehem, Penn.-based B. Braun did not release any details of the acquisition, and has not revealed how it plans to integrate the business into its existing product lines. “We are pleased to add the Streamline bloodline to our dialysis product portfolio. Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamline’s benefits as part of our transformative system of products, which includes...
Source: Mass Device - July 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions B. Braun NxStage Medical Inc. Source Type: news

Sanovas CEO Gerrans indicted on fraud, money laundering charges
A federal grand jury last week indicted Sanovas president & CEO Larry Gerrans on three counts of wire fraud and money laundering for alleged schemes to pay cash for a home and “myriad” personal expenses. Gerrans has denied the charges via a company spokesman. According to federal prosecutors and the FBI, Gerrans “employed a number of fraudulent methods to syphon funds out of Sanovas” from April 2013 to May 2015, including the withdrawal of $500,000 from his personal IRA to pay for personal vacations, jewelry and spa treatments. Prosecutors alleged that Gerrans told a newly convened boa...
Source: Mass Device - July 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Respiratory Wall Street Beat Sanovas Source Type: news

How California ’s recreational cannabis rush is hurting some critically ill patients
The introduction of recreational cannabis in California has opened up a multi-billion dollar business opportunity as the industry moves mainstream, but it also poses questions about what will happen to the medical market that paved the way for legalization. Even with though many fewer companies than anticipated jumped into the legal market this year due to uncertain regulations, cannabis research firm BDS Analytics estimates $3.1 billion in recreational spending for 2018. Legal medical cannabis… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 19, 2018 Category: American Health Authors: Kevin Truong Source Type: news

Make cannabis-based medicines legal, say UK drug advisers
Advisory council ’s recommendation may pave way for loosening of lawsDoctors in the UK should be able to prescribe cannabis-derived medicine, the government ’s chief drug advisers have recommended, paving the way for a loosening of the laws governing access to the substance.The Advisory Council on the Misuse of Drugs (ACMD) has recommended after a review that cannabis-derived medicinal products should be placed in schedule 2 of the misuse of drugs regulations 2001, allowing them to be prescribed by clinicians.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 19, 2018 Category: Science Authors: Jamie Grierson Home affairs correspondent Tags: Cannabis UK news Epilepsy Sajid Javid Drugs Politics Society Drugs policy Science Source Type: news

How California ’s recreational cannabis rush is hurting some critically ill patients
The introduction of recreational cannabis in California has opened up a multibillion-dollar business opportunity as the industry moves mainstream, but it also poses questions about what will happen to the medical market that paved the way for legalization. Even with though many fewer companies than anticipated jumped into the legal market this year due to uncertain regulations, cannabis research firm BDS Analytics estimates $3.1 billion in recreational spending for 2018. Legal medical cannabis… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 19, 2018 Category: American Health Authors: Kevin Truong Source Type: news

Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016
Among persons living with HBV worldwide, approximately 27 million (10.5%) were aware of their infection, including 4.5 million (16.7%) who were on treatment. In 2017, all but two low- and middle-income countries could legally procure generic entecavir or tenofovir, the medicines active against HBV infection. (Source: PHPartners.org)
Source: PHPartners.org - July 19, 2018 Category: International Medicine & Public Health Source Type: news